THE USE OF PAINKILLERS IN MEDICAL PRACTICE, SIDE EFFECTS AND THE RELEVANCE OF THE SEARCH FOR HIGHLY EFFECTIVE AND SAFE DRUGS

Authors

  • Pakhlavon Qakhramonovich Turdiev Head teacher of the Department of Pharmacology of Tashkent State Medical University, Tashkent, Uzbekistan.
  • Madina Khursand qizi Khajibaeva Student of the group 303B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan.
  • Madinabonu Ilkhomjon qizi Mo‘ydinova Student of the group 303B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan.
  • Musaffo Alijon qizi To‘rajonova Student of the group 305B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan.
  • Marjona Sherali qizi Khamraeva Student of the group 307B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan.
  • Otabek Alijon o‘g‘li Nazarov Student of the group 105A, 2nd Faculty of Dentistry of Tashkent State Medical University, Tashkent, Uzbekistan.

Keywords:

morphine, opioids, analgesia, behavior, side effects, chronic pain, tolerance.

Abstract

 In order to reduce discomfort and enhance the quality of life for those with acute or chronic pain, pain management is an essential component of healthcare. The main strategy for managing pain is pharmacological approaches, which include a wide range of medications that function via various mechanisms. According to the review's findings, a multimodal strategy that combines several analgesics can improve pain management while reducing side effects. In order to maximize the results of pain management, it highlights the significance of evaluating the severity of pain, identifying the underlying cause, and applying evidence-based recommendations. In order to minimize side effects and achieve the best possible pain relief, pharmacological pain management techniques are a crucial part of pain management strategies. A review of new developments and potential paths in pharmacological pain management, such as innovative drug targets and improvements in drug delivery systems, is included in the article's conclusion. In order to treat moderate to severe acute and chronic pain, opioids are frequently employed as therapeutic agents. However, because they cause analgesic tolerance, addiction, and a variety of behavioral side effects that frequently lead to patient non-compliance, these kinds of analgesic medications have several potential drawbacks. Since opium and opioids have historically been used to treat pain, the precise processes underlying their negative side effects after chronic usage are complex and poorly understood. Due to aging-related physiological changes and decreased metabolic capacity, older persons experience greater chronic pain from cancer and non-cancer conditions than younger adults. As a result, they experience more adverse reactions to opioid medications.

 

References

Alorfi NM. Pharmacological Methods of Pain Management: Narrative Review of Medication Used. Int J Gen Med. 2023 Jul 31;16:3247-3256. doi: 10.2147/IJGM.S419239.

Queremel Milani DA, Davis DD. Pain Management Medications. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560692/

InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Using medication: Learn More – The safe use of over-the-counter painkillers. [Updated 2025 Dec 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK361006/

Paul AK, Smith CM, Rahmatullah M, Nissapatorn V, Wilairatana P, Spetea M, Gueven N, Dietis N. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. Pharmaceuticals (Basel). 2021 Oct 27;14(11):1091. doi: 10.3390/ph14111091.

Raja SN, Carr DB, Cohen M, et al. The revised IASP definition of pain: concepts, challenges, and compromises. Pain. 2020;161:1976. doi: 10.1097/J.PAIN.0000000000001939

Yam MF, Loh YC, Tan CS, Adam SK, Manan NA, Basir R. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 2018;19:2164. doi: 10.3390/IJMS19082164

Ohashi N, Kohno T. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020;11:1916. doi: 10.3389/FPHAR.2020.580289/BIBTEX

Chen R, Coppes OJM, Urman RD. Receptor and molecular targets for the development of novel opioid and non-opioid analgesic therapies. Pain Physician. 2021;24:153–163. doi: 10.36076/ppj.2021.24.153-163.

Ma RS, Kayani K, Whyte-Oshodi D, et al. Voltage gated sodium channels as therapeutic targets for chronic pain. J Pain Res. 2019;12:2709. doi: 10.2147/JPR.S207610

Scherrmann J-M, Wolff K, Franco CA, et al. Allodynia. Encycl Psychopharmacol. 2022:65. doi: 10.1007/978-3-540-68706-1_1043

Moisset X, Bouhassira D, Avez Couturier J, et al. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol. 2020;176:325–352. doi: 10.1016/J.NEUROL.2020.01.361

Yu K, Niu X, He B, Yu K, Niu X, He B. Neuromodulation management of chronic neuropathic pain in the central nervous system. Adv Funct Mater. 2020;30:1908999. doi: 10.1002/ADFM.201908999

Knotkova H, Hamani C, Sivanesan E, et al. Neuromodulation for chronic pain. Lancet. 2021;397:2111–2124. doi: 10.1016/S0140-6736(21)00794-7

Alorfi NM. Prescribing patterns and pharmacological knowledge of analgesics among community pharmacists in Jeddah, Saudi Arabia. Bull Pharm Sci Assiut. 2023;46:647–657. doi: 10.21608/BFSA.2023.301293

Mullins S, Hosseini F, Gibson W, Thake M. Physiological changes from ageing regarding pain perception and its impact on pain management for older adults. Clin Med. 2022;22:307. doi: 10.7861/CLINMED.22.4.PHYS

Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022;163:E328–E332. doi: 10.1097/J.PAIN.0000000000002291

Alorfi NM, Alqurashi RS, Algarni AS. Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia. Front Pharmacol. 2023;14. doi: 10.3389/FPHAR.2023.1209318

Pena D.A., Duarte M.L., Pramio D.T., Devi L.A., Schechtman D. Exploring morphine-triggered PKC-targets and their interaction with signaling pathways leading to pain via TrkA. Proteomes. 2018;6:39. doi: 10.3390/proteomes6040039.

Lei H., Zhang Y., Huang L., Xu S., Li J., Yang L., Wang L., Xing C., Wang X., Peng Y. L-3-n-Butylphthalide regulates proliferation, migration, and differentiation of neural stem cell in vitro and promotes neurogenesis in APP/PS1 mouse model by regulating BDNF/TrkB/CREB/Akt pathway. Neurotox. Res. 2018;34:477–488. doi: 10.1007/s12640-018-9905-3.

Jin Z., Zhu M., Gupta A., Page C., Gan T.J., Bergese S.D. Evaluating oliceridine as a treatment option for moderate to severe acute post-operative pain in adults. Expert Opin. Pharmacother. 2021:1–9. doi: 10.1080/14656566.2021.1982893.

Hammer G.B., Khanna A.K., Michalsky C., Wase L., Demitrack M.A., Little R., Fossler M.J., Ayad S. Oliceridine exhibits improved tolerability compared to morphine at equianalgesic conditions: Exploratory analysis from two phase 3 randomized placebo and active controlled trials. Pain Ther. 2021:1–11. doi: 10.1007/s40122-021-00299-0.

Listos J., Łupina M., Talarek S., Mazur A., Orzelska-Górka J., Kotlińska J. The mechanisms involved in morphine addiction: An overview. Int. J. Mol. Sci. 2019;20:4302. doi: 10.3390/ijms20174302.

Hill R., Santhakumar R., Dewey W., Kelly E., Henderson G. Fentanyl depression of respiration: Comparison with heroin and morphine. Br. J. Pharmacol. 2020;177:254–265. doi: 10.1111/bph.14860.

Cunningham C.W., Elballa W.M., Vold S.U. Bifunctional opioid receptor ligands as novel analgesics. Neuropharmacology. 2019;151:195–207. doi: 10.1016/j.neuropharm.2019.03.006.

Tzschentke T.M., Linz K., Koch T., Christoph T. Cebranopadol: A novel first-in-class potent analgesic acting via NOP and opioid receptors. Antisense Res. Appl. 2019;254:367–398. doi: 10.1007/164_2019_206.

IASP Pain, IASP Terminology. International Association for the Study of Pain (IASP) [(accessed on 26 October 2021)]. Available online: https://www.iasp-pain.org/resources/terminology/#pain.

Fitzcharles M.-A., Cohen S.P., Clauw D.J., Littlejohn G., Usui C., Häuser W. Nociplastic pain: Towards an understanding of prevalent pain conditions. Lancet. 2021;397:2098–2110. doi: 10.1016/S0140-6736(21)00392-5.

Nijs J., Lahousse A., Kapreli E., Bilika P., Saraçoğlu I., Malfliet A., Coppieters I., De Baets L., Leysen L., Roose E., et al. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J. Clin. Med. 2021;10:3203. doi: 10.3390/jcm10153203.

Downloads

Published

2026-05-05